Correction: American Journal of Cardiovascular Drugs (2024) 24:197–209 https://doi.org/10.1007/s40256-024-00634-8


In this article the corporate e-mail address of the corresponding author dora.molina@ucaldas.edu.co should have been included.


In the Acknowledgements, Funding and Conflicts of Interest section of this article the funder name was incorrectly given as Tecnimede - Sociedade Técnico Medicinal, S.A. and should have been Altadis/Group Tecnimede.


The original article has been corrected.